UPDATE 1-Mylan says merger with Teva would be bad fit

April 17, 2015 7:31 PM

3 0

April 17 (Reuters) - Generic drugmaker Mylan NV moved quickly on Friday to pour cold water on published reports that Teva Pharmaceuticals Industries is considering a bid to acquire it.

Mylan last week announced a $29 billion offer to buy Perrigo Co Plc in a move that some analysts suggested was a tactic to help fend off an acquisition by larger rival Teva.

Also read: ECB sets Banco Popular's 2017 capital level at 7.875 percent

Read more

To category page

Loading...